GT200000158A - PIRIDINES AND REPLACED PYRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY. - Google Patents
PIRIDINES AND REPLACED PYRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY.Info
- Publication number
- GT200000158A GT200000158A GT200000158A GT200000158A GT200000158A GT 200000158 A GT200000158 A GT 200000158A GT 200000158 A GT200000158 A GT 200000158A GT 200000158 A GT200000158 A GT 200000158A GT 200000158 A GT200000158 A GT 200000158A
- Authority
- GT
- Guatemala
- Prior art keywords
- piridines
- replaced
- inhibition activity
- pyridacines
- angiogenesis inhibition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Abstract
LA INVENCION SE REFIERE A PRODUCTOS FARMACEUTICOS HETEROCICLICOS DE MOLECULAS PEQUEÑAS, Y MAS PARTICULARMENTE, A PIRIDINAS Y PIRIDACINAS SUSTITUIDAS QUE TIENEN ACTIVIDAD DE INHIBICION DE ANGIOGENESIS.THE INVENTION REFERS TO HETEROCICLIC PHARMACEUTICAL PRODUCTS OF SMALL MOLECULES, AND MORE PARTICULARLY, TO PIRIDINES AND REPLACED PIRIDINES THAT HAVE ANGIOGENESIS INHIBITION ACTIVITY.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40760099A | 1999-09-28 | 1999-09-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200000158A true GT200000158A (en) | 2002-03-16 |
Family
ID=23612752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200000158A GT200000158A (en) | 1999-09-28 | 2000-09-22 | PIRIDINES AND REPLACED PYRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY. |
Country Status (36)
Country | Link |
---|---|
EP (1) | EP1228063B1 (en) |
JP (1) | JP4919567B2 (en) |
KR (3) | KR100895572B1 (en) |
CN (3) | CN100374435C (en) |
AR (3) | AR025752A1 (en) |
AT (1) | ATE422494T1 (en) |
AU (1) | AU782820B2 (en) |
BG (1) | BG65860B1 (en) |
BR (1) | BRPI0014382B8 (en) |
CA (1) | CA2385817C (en) |
CO (1) | CO5200835A1 (en) |
CZ (1) | CZ304767B6 (en) |
DE (1) | DE60041548D1 (en) |
DO (1) | DOP2000000070A (en) |
EE (1) | EE05258B1 (en) |
ES (1) | ES2320525T3 (en) |
GT (1) | GT200000158A (en) |
HK (2) | HK1091818A1 (en) |
HR (1) | HRP20020308A2 (en) |
HU (1) | HU230223B1 (en) |
IL (3) | IL148880A0 (en) |
MA (1) | MA25563A1 (en) |
MX (1) | MXPA02003156A (en) |
MY (3) | MY135058A (en) |
NO (1) | NO20021520L (en) |
NZ (1) | NZ518589A (en) |
PA (1) | PA8503201A1 (en) |
PE (1) | PE20010607A1 (en) |
PL (1) | PL205957B1 (en) |
RS (1) | RS50369B (en) |
RU (1) | RU2260008C2 (en) |
SK (1) | SK287417B6 (en) |
TW (1) | TW593315B (en) |
UA (1) | UA75053C2 (en) |
WO (1) | WO2001023375A2 (en) |
ZA (1) | ZA200202760B (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2416525A1 (en) * | 2000-08-09 | 2002-02-14 | Astrazeneca Ab | Indole, azaindole and indazole derivatives having vegf inhibiting activity |
ES2318649T3 (en) | 2000-10-20 | 2009-05-01 | EISAI R&D MANAGEMENT CO., LTD. | PROCEDURE FOR PREPARATION OF DERIVATIVES OF 4-FENOXI QUINOLINAS. |
US20050019424A1 (en) * | 2001-12-21 | 2005-01-27 | Adams Paul E. | Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives |
TWI299664B (en) | 2003-01-06 | 2008-08-11 | Osi Pharm Inc | (2-carboxamido)(3-amino)thiophene compounds |
WO2004080464A1 (en) * | 2003-03-11 | 2004-09-23 | Novartis Ag | Use of isoquinoline derivatives for treating cancer and map kinase related diseases |
US20070082910A1 (en) * | 2003-04-08 | 2007-04-12 | Mitsubishi Pharma Corporation | Specific nad(p)h oxidase inhibitor |
CN101337930B (en) | 2003-11-11 | 2010-09-08 | 卫材R&D管理有限公司 | Urea derivative preparation process |
KR100553398B1 (en) * | 2004-03-12 | 2006-02-16 | 한미약품 주식회사 | METHOD OF PREPARING THIENO [3,2-c]PYRIDINE DERIVATIVES AND INTERMEDIATES USED THEREIN |
EP2364699A1 (en) | 2004-09-13 | 2011-09-14 | Eisai R&D Management Co., Ltd. | Joint use of sulfonamide based compound with angiogenesis inhibitor |
US8772269B2 (en) | 2004-09-13 | 2014-07-08 | Eisai R&D Management Co., Ltd. | Use of sulfonamide-including compounds in combination with angiogenesis inhibitors |
US8969379B2 (en) | 2004-09-17 | 2015-03-03 | Eisai R&D Management Co., Ltd. | Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide |
WO2007015578A1 (en) | 2005-08-02 | 2007-02-08 | Eisai R & D Management Co., Ltd. | Method for assay on the effect of vascularization inhibitor |
US8304406B2 (en) | 2006-04-15 | 2012-11-06 | Bayer Intellectual Property Gmbh | Compounds for treating pulmonary hypertension |
CA2652442C (en) | 2006-05-18 | 2014-12-09 | Eisai R & D Management Co., Ltd. | Antitumor agent for thyroid cancer |
KR101472600B1 (en) | 2006-08-28 | 2014-12-15 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Antitumor agent for undifferentiated gastric cancer |
CA2676796C (en) | 2007-01-29 | 2016-02-23 | Eisai R & D Management Co., Ltd. | Composition for treatment of undifferentiated gastric cancer |
WO2009060945A1 (en) | 2007-11-09 | 2009-05-14 | Eisai R & D Management Co., Ltd. | Combination of anti-angiogenic substance and anti-tumor platinum complex |
CN101481380B (en) * | 2008-01-08 | 2012-10-17 | 浙江医药股份有限公司新昌制药厂 | Thiofuran pyridazine compound, preparation thereof, pharmaceutical composition and uses thereof |
EP2586443B1 (en) | 2010-06-25 | 2016-03-16 | Eisai R&D Management Co., Ltd. | Antitumor agent using compounds having kinase inhibitory effect in combination |
CA2828946C (en) | 2011-04-18 | 2016-06-21 | Eisai R&D Management Co., Ltd. | Therapeutic agent for tumor |
ES2705950T3 (en) | 2011-06-03 | 2019-03-27 | Eisai R&D Man Co Ltd | Biomarkers to predict and assess the responsiveness of subjects with thyroid and kidney cancer to lenvatinib compounds |
CN104755463A (en) | 2012-12-21 | 2015-07-01 | 卫材R&D管理有限公司 | Amorphous form of quinoline derivative, and method for producing same |
MX368099B (en) | 2013-05-14 | 2019-09-19 | Eisai R&D Man Co Ltd | Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds. |
CN103396361B (en) * | 2013-07-24 | 2016-05-04 | 中国人民解放军第二军医大学 | 3,4-dihydro-isoquinoline anti-tumor compounds and preparation method thereof and application |
JO3783B1 (en) | 2014-08-28 | 2021-01-31 | Eisai R&D Man Co Ltd | Highly pure quinoline derivative and method for producing the same |
DK3263106T3 (en) | 2015-02-25 | 2024-01-08 | Eisai R&D Man Co Ltd | PROCESS FOR SUPPRESSING BITTERNESS OF QUINOLINE DERIVATIVES |
CA2978226A1 (en) | 2015-03-04 | 2016-09-09 | Merck Sharpe & Dohme Corp. | Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer |
CN104804008B (en) * | 2015-03-27 | 2016-03-23 | 亿腾药业(泰州)有限公司 | A kind of method of suitability for industrialized production methylsulfonic acid Telatinib |
CN107801379B (en) | 2015-06-16 | 2021-05-25 | 卫材R&D管理有限公司 | Anticancer agent |
CN107129502B (en) * | 2017-04-13 | 2022-08-05 | 泰州亿腾景昂药业股份有限公司 | EOC315Mod.I crystal form compound and preparation method thereof |
CN112830932B (en) * | 2020-12-25 | 2022-04-08 | 泰州亿腾景昂药业股份有限公司 | Free base crystal form of teratinib, preparation method and application thereof |
WO2023081923A1 (en) | 2021-11-08 | 2023-05-11 | Frequency Therapeutics, Inc. | Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1453897A (en) * | 1965-06-16 | 1966-07-22 | Thiophene and thienopyridazine derivatives | |
GB1094044A (en) * | 1965-07-12 | 1967-12-06 | Vantorex Ltd | Phthalazine derivatives |
FR1516777A (en) * | 1966-08-02 | 1968-02-05 | Innothera Lab Sa | Thiazole derivatives as well as thiazolo [4,5-d] pyridazine and their preparation |
GB1293565A (en) * | 1969-05-03 | 1972-10-18 | Aspro Nicholas Ltd | Aminophthalazines and pharmaceutical compositions thereof |
JPH03106875A (en) * | 1989-09-20 | 1991-05-07 | Morishita Pharmaceut Co Ltd | 1-(3-pyridylmethyl)phthalazine derivative |
AU705229B2 (en) * | 1994-08-09 | 1999-05-20 | Eisai R&D Management Co., Ltd. | Fused pyridazine compound |
CO4950519A1 (en) * | 1997-02-13 | 2000-09-01 | Novartis Ag | PHTHALAZINES, PHARMACEUTICAL PREPARATIONS THAT UNDERSTAND THEM AND THE PROCESS FOR THEIR PREPARATION |
ATE459616T1 (en) * | 1998-08-11 | 2010-03-15 | Novartis Ag | ISOCHINOLINE DERIVATIVES WITH ANGIOGENESIS-INHIBITING EFFECT |
DE60028740T2 (en) * | 1999-03-30 | 2007-05-24 | Novartis Ag | PHTHALAZINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES |
AR025068A1 (en) * | 1999-08-10 | 2002-11-06 | Bayer Corp | PIRAZINAS REPLACED AND FUSIONATED PYRIDAZINES, PHARMACEUTICAL COMPOSITION THAT INCLUDE THEM, USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT WITH AN ANGIOGENESIS INHIBITING ACTIVITY |
PT1254138E (en) * | 2000-02-09 | 2005-09-30 | Novartis Ag | PYRIDINE DERIVATIVES THAT INHIBIT ANGIOGENESE AND / OR VIRUS TYROSINE KINASE RECEPTOR |
-
2000
- 2000-09-22 GT GT200000158A patent/GT200000158A/en unknown
- 2000-09-22 CO CO00072226A patent/CO5200835A1/en active IP Right Grant
- 2000-09-22 DO DO2000000070A patent/DOP2000000070A/en unknown
- 2000-09-22 AR ARP000104981A patent/AR025752A1/en not_active Application Discontinuation
- 2000-09-25 MY MYPI20004467A patent/MY135058A/en unknown
- 2000-09-25 MY MYPI20051063A patent/MY143580A/en unknown
- 2000-09-25 TW TW089119700A patent/TW593315B/en not_active IP Right Cessation
- 2000-09-25 PA PA20008503201A patent/PA8503201A1/en unknown
- 2000-09-25 MY MYPI20051064A patent/MY143377A/en unknown
- 2000-09-25 PE PE2000001004A patent/PE20010607A1/en not_active Application Discontinuation
- 2000-09-26 KR KR1020087021380A patent/KR100895572B1/en active IP Right Grant
- 2000-09-26 AU AU15696/01A patent/AU782820B2/en not_active Expired
- 2000-09-26 BR BRPI0014382A patent/BRPI0014382B8/en not_active IP Right Cessation
- 2000-09-26 SK SK591-2002A patent/SK287417B6/en not_active IP Right Cessation
- 2000-09-26 JP JP2001526527A patent/JP4919567B2/en not_active Expired - Lifetime
- 2000-09-26 CN CNB008163693A patent/CN100374435C/en not_active Expired - Lifetime
- 2000-09-26 UA UA2002043504A patent/UA75053C2/en unknown
- 2000-09-26 ES ES00978215T patent/ES2320525T3/en not_active Expired - Lifetime
- 2000-09-26 CA CA2385817A patent/CA2385817C/en not_active Expired - Lifetime
- 2000-09-26 KR KR1020027003972A patent/KR100890473B1/en active IP Right Grant
- 2000-09-26 CN CNB2005101271105A patent/CN100422173C/en not_active Expired - Lifetime
- 2000-09-26 DE DE60041548T patent/DE60041548D1/en not_active Expired - Lifetime
- 2000-09-26 KR KR1020087021379A patent/KR100895571B1/en active IP Right Grant
- 2000-09-26 AT AT00978215T patent/ATE422494T1/en not_active IP Right Cessation
- 2000-09-26 NZ NZ518589A patent/NZ518589A/en not_active IP Right Cessation
- 2000-09-26 PL PL366342A patent/PL205957B1/en unknown
- 2000-09-26 CN CNB2005101271092A patent/CN100422172C/en not_active Expired - Lifetime
- 2000-09-26 IL IL14888000A patent/IL148880A0/en active IP Right Grant
- 2000-09-26 EE EEP200200161A patent/EE05258B1/en not_active IP Right Cessation
- 2000-09-26 RS YUP-229/02A patent/RS50369B/en unknown
- 2000-09-26 HU HU0202704A patent/HU230223B1/en not_active IP Right Cessation
- 2000-09-26 EP EP00978215A patent/EP1228063B1/en not_active Expired - Lifetime
- 2000-09-26 RU RU2002111414/04A patent/RU2260008C2/en active
- 2000-09-26 WO PCT/US2000/026500 patent/WO2001023375A2/en active Application Filing
- 2000-09-26 CZ CZ2002-1444A patent/CZ304767B6/en not_active IP Right Cessation
- 2000-09-26 MX MXPA02003156A patent/MXPA02003156A/en active IP Right Grant
-
2002
- 2002-03-26 NO NO20021520A patent/NO20021520L/en unknown
- 2002-04-09 ZA ZA200202760A patent/ZA200202760B/en unknown
- 2002-04-10 HR HR20020308A patent/HRP20020308A2/en not_active IP Right Cessation
- 2002-04-23 BG BG106637A patent/BG65860B1/en unknown
- 2002-04-26 MA MA26619A patent/MA25563A1/en unknown
-
2006
- 2006-11-08 HK HK06112289.9A patent/HK1091818A1/en not_active IP Right Cessation
- 2006-11-08 HK HK06112290.6A patent/HK1091819A1/en unknown
-
2008
- 2008-08-11 IL IL193367A patent/IL193367A/en active IP Right Grant
- 2008-08-11 IL IL193368A patent/IL193368A/en active IP Right Grant
-
2011
- 2011-07-15 AR ARP110102558A patent/AR082231A2/en unknown
- 2011-07-15 AR ARP110102559A patent/AR082232A2/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200000158A (en) | PIRIDINES AND REPLACED PYRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY. | |
HN1999000066A (en) | PHARMACEUTICAL FORMULATIONS | |
EE200300212A (en) | Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic diseases | |
BRPI0010891B8 (en) | generation of therapeutic microfoam. | |
NL1015859A1 (en) | Pharmaceutical preparations. | |
PA8466601A1 (en) | NEW AROMATIC AMIDES, THEIR PREPARATION PROCEDURE AND THEIR APPLICATION AS MEDICINES | |
DZ3170A1 (en) | Delivery of unstable pharmaceuticals. | |
PT1173434E (en) | NEW PHARMACEUTICAL PRODUCT | |
SE9901077D0 (en) | Novel use | |
UY27270A1 (en) | COMPRESSED MELOXICAM FAST DISGREGATION | |
MA27889A1 (en) | TABLET CONTAINING FLUVASTATIN AND CALCIUM CARMELLOSIS | |
DE50105771D1 (en) | IBUPROFEN-ACTIVE PREPARATION | |
ECSP003707A (en) | DIAZEPANES | |
ITMI20001827A0 (en) | ANTI-INFLAMMATORY MEDICINAL PRODUCT | |
CR7198A (en) | TABLET CONTAINING CETIRIZINE AND PSEUDOEFEDRINE | |
BR0003625B1 (en) | hygienic tampon resistant to compression. | |
NO20032154L (en) | Crosslinked cellulosic product | |
ITMI20000293A0 (en) | DERIVATIVES OF 3,9-DIAZACYCLE [3.3.1]NOT HAVE ANALGESIC ACTIVITY | |
MA26604A1 (en) | PHARMACEUTICAL COMPOSITIONS. | |
CR7819A (en) | UNIT FOR DAILY DOSAGE OF MELATONIN | |
DZ2159A1 (en) | Pharmaceutical products. | |
HN1998000094A (en) | PHARMACEUTICAL COMPOSITIONS THAT HAVE APPETITE SUPPRESSIVE ACTIVITY | |
ITMO20000208A0 (en) | CLADDING PRODUCT | |
PT1326494E (en) | PSEUDOMICINAS UTEIS AGAINST PLANT DISEASES | |
PT1235809E (en) | SUBSTITUTED 1,2,3,4,5,6-HEXA-HYDRO-2,6-METHANE-3-BENZAZOCINES AND THEIR USE AS MEDICINES |